Avinger to present at the h.c. wainwright 23rd annual global investment conference september 13-15

Redwood city, ca / accesswire / september 8, 2021 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced that its management will participate in investor meetings september 13-15, 2021 as part of the h.c. wainwright 23rd annual global investment conference.
AVGR Ratings Summary
AVGR Quant Ranking